Amended Current Report Filing (8-k/a)
April 14 2017 - 11:29AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K/A
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported):
November 14, 2016
NUGENE INTERNATIONAL, INC.
(Exact name of registrant as specified in its
charter)
NEVADA
|
001-37940
|
46-3999052
|
(State or other jurisdiction of
incorporation)
|
(Commission File Number)
|
(IRS Employer Identification
Number)
|
17912 Cowan
Irvine, California 92614
(Address of Principal Executive Offices)
(949) 430-7737
(Registrant’s telephone number including
area code)
Not Applicable
(Former name or former address, if changed since
last report)
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
|
¨
|
Written
communications pursuant to Rule 425 under the Securities Act (17CFR 230.425)
|
|
¨
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
¨
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
¨
|
Pre-commencement communications pursuant to Rule
13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Explanatory Note
This Current Report on
Form 8-K/A (this “
Amendment
”) amends the Current Report on Form 8-K filed by NuGene International, Inc. (the
“
Company
”) with the Securities and Exchange Commission (the “
SEC
”) on 18 November 2016 (the
“
Original Report
”) relating to the Company’s change in certifying accountant. The purpose of this Form
8-K/A is to file a copy of the letter received by the Company 09 April 2017 from the Company’s prior auditor. The letter,
dated 09 April 2017 and addressed to the SEC, was provided in response to the Company’s request whether the former auditor
agreed with the statements in the Original Report.
This Amendment amends the
Original Report by adding the following language:
|
Item 4.01
|
Change in Registrant’s Certifying Accountant
|
(v) On 14 November 2016 the Company
provided Dov Weinstein with its disclosures in the Current Report on Form 8-K disclosing the dismissal of Dov Weinstein and requested
in writing that Dov Weinstein furnish the Company with a letter addressed to the Securities and Exchange Commission stating whether
or not they agree with such disclosures. A copy of the letter, dated 09 April 2017, is filed as Exhibit 16.1 to this Current Report
on Form 8-K/A and is incorporated by reference herein.
|
Item 9.01
|
Financial Statements and Exhibits
|
SIGNATURE
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized.
Date: 13 April 2017
|
NUGENE INTERNATIONAL, INC.
|
|
|
|
By:
|
/s/ Steven R. Carlson
|
|
|
Steven R. Carlson,
|
|
|
Chief Executive Officer
|
NuGene (PK) (USOTC:NUGN)
Historical Stock Chart
From Mar 2024 to Apr 2024
NuGene (PK) (USOTC:NUGN)
Historical Stock Chart
From Apr 2023 to Apr 2024